IP Library Granted Patent US 12692233
Granted Patent B2
US 12692233 · App. 18/256,094 · Granted Jul 28, 2026

Anthelmintic compounds comprising a pyridine structure

Inventors: Michael Berger (Wiesbaden, DE); Michael Linder (Ingelheim, DE); Carolin Schneider (Hofheim, DE); Janina Tänzler (Nierder-Olm, DE); Ulrich Sondern (Dortmund, DE)
Assignee: Intervet Inc.
C07D213/71A61P33/10C07D413/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12692233
App. No.
18/256,094
Granted
Jul 28, 2026
Kind
B2
Abstract

The present invention relates to new anthelmintic compounds. These compounds can for example be used in the treatment of the kind of worm disease caused by helminths such as Dirofilaria , in particular Dirofilaria immitis.

Claims (872)

1 . A Compound of Formula (I)

wherein

L is independently selected from

being absent, —CH 2 —, —NR L —, —O—, —S—, —S(O)— and —S(O) 2 —, with R L being independently selected from hydrogen and C 1-3 -alkyl,

R 1 is independently selected from the group consisting of

hydrogen, C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, C 1-6 -alkylmercapto, halogen, cyano, nitro, hydroxy, mercapto, NR 2 R 3 , COOH, C(═O)OR 4 , SR 4 , S(O)R 4 , S(O) 2 R 4 , S(O) 2 NR 5 R 6 and C(═O)NR 5 R 6 ,

wherein each C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy or C 1-6 -alkylmercapto, is optionally substituted with one or more substituent(s) independently selected from the group consisting of

C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, C 1-6 -alkylmercapto, halogen, cyano, nitro, hydroxy, mercapto, NR 2′ R 3′ , C(═O)OR 4′ , SR 4′ , S(O)R 4′ , S(O) 2 R 4′ , S(O) 2 NR 5′ R 6′ and C(═O)NR 5′ R 6′ ,

R 2 and R 3 are independently selected from the group consisting of

hydrogen, C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy-C 1-6 -alkyl, C 1-6 -alkyl substituted with C 3-10 -cycloalkyl, C 1-6 -alkyl substituted with 4 to 10-membered heterocyclyl, C 1-6 -alkyl substituted with C 6-10 -aryl and C 1-6 -alkyl substituted with 5 to 10-membered heteroaryl, or

R 2 and R 3 together with the N atom to which they are attached form a saturated or unsaturated heterocyclic ring having 3 to 12 ring atoms, wherein 0, 1, 2 or 3 further ring atoms are selected from N, S and O,

wherein each C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy-C 1-6 -alkyl, C 1-6 -alkyl substituted with C 3-10 -cycloalkyl, C 1-6 -alkyl substituted with 4 to 10-membered heterocyclyl, C 1-6 -alkyl substituted with C 6-10 -aryl, C 1-6 -alkyl substituted with 5 to 10-membered heteroaryl or the heterocyclic ring formed by R 2 and R 3 together with the N atom to which they are attached is optionally substituted with one or more substituent(s) independently selected from the group consisting of

C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, carbonyl, halogen, cyano, hydroxy, mercapto, NR 2″ R 3″ , C(═O)OR 4″ , SR 4″ , S(O)R 4″ , S(O) 2 R 4″ , S(O) 2 NR 5″ R 6″ and C(═O)NR 5″ R 6″ ,

R 4 , R 5 and R 6 are independently selected from hydrogen and C 1-6 -alkyl,

R 2′ , R 3′ , R 4′ , R 5′ and R 6′ are independently selected from hydrogen and C 1-6 -alkyl,

R 2″ , R 3″ , R 4″ , R 5″ and R 6″ are independently selected from hydrogen and C 1-6 -alkyl,

R 7 is independently selected from the group consisting of

methyl, ethyl, isopropyl, isopropenyl, methoxy, ethoxy, isopropoxy, hydroxy, methylmercapto, ethylmercapto, methyl sulfoxyl, methyl sulfonyl, methylthio, amino, methylamino, ethylamino, isopropylamino, dimethylamino, isopropylmethylamino, hydroxyethylamino, methoxyethylamino, morpholin-4-yl, 4-methylpiperazin-1-yl, 3-hydroxy-pyrrolidin-1-yl, 3-fluoroazetidin-1-yl and 3,3-difluoroazetidin-1-yl,

R 8 and R 9 are independently selected from the group consisting of

hydrogen, C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy-C 1-6 -alkyl, C 1-6 -alkyl substituted with C 3-10 -cycloalkyl, C 1-6 -alkyl substituted with 4 to 10-membered heterocyclyl, C 1-6 -alkyl substituted with C 6-10 -aryl and C 1-6 -alkyl substituted with 5 to 10-membered heteroaryl, or

R 8 and R 9 together with the N atom to which they are attached form a saturated or unsaturated heterocyclic ring having 3 to 12 ring atoms, wherein 0, 1, 2 or 3 further ring atoms are selected from N, S and O,

wherein each C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy-C 1-6 -alkyl, C 1-6 -alkyl substituted with C 3-10 -cycloalkyl, C 1-6 -alkyl substituted with 4 to 10-membered heterocyclyl, C 1-6 -alkyl substituted with C 6-10 -aryl, C 1-6 -alkyl substituted with 5 to 10-membered heteroaryl or the heterocyclic ring formed by R 8 and R 9 together with the N atom to which they are attached is optionally substituted with one or more substituent(s) independently selected from the group consisting of

C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, carbonyl, halogen, cyano, hydroxy, mercapto, NR 8″ R 9″ , C(═O)OR 10″ , SR 10″ , S(O)R 10″ , S(O) 2 R 10″ , S(O) 2 NR 11″ R 12″ and C(═O)NR 11″ R 12″ ,

R 10 , R 11 and R 12 are independently selected from hydrogen and C 1-6 -alkyl,

R 8′ , R 9′ , R 10′ , R 11′ and R 12′ are independently selected from hydrogen and C 1-6 -alkyl,

R 8″ , R 9″ , R 10″ , R 11″ and R 12″ are independently selected from hydrogen and C 1-6 -alkyl,

R 13 and R 14 together with the atoms to which they are attached form a 5 or 6-carbon atoms containing saturated ring, wherein the saturated ring is optionally substituted with one or more C 1-3 -alkyl or ═O, and/or wherein one or more of the ring-forming carbon atoms are optionally replaced by —NH—, —O—, —S(O)—, —S(O) 2 — or —S—, or

R 13 and R 14 together with the atoms to which they are attached form a 5 or 6-carbon atoms containing unsaturated ring, wherein the unsaturated ring is optionally substituted with one or more C 1-3 -alkyl, and/or wherein one or more of the ring-forming carbon atoms are optionally replaced by —NH—, —N═, =N—, —O— or —S—,

A1 is N or CR 15 , wherein R 15 is independently hydrogen, halogen, C 1-3 alkyl, C 1-3 alkoxy, or NR 15′ R 15″ , wherein R 15′ and R 15″ are independently C 1-3 -alkyl,

A2 is N or CR 16 , wherein R 16 is independently hydrogen, halogen, C 1-3 alkyl, C 1-3 alkoxy, or NR 16′ R 16″ , wherein R 16′ and R 16″ are independently C 1-3 -alkyl,

A3 is N or CR 17 , wherein R 17 is independently hydrogen, halogen, C 1-3 alkyl, C 1-3 alkoxy, or NR 17′ R 17″ , wherein R 17′ and R 17″ are independently C 1-3 -alkyl,

A4 is N or CR 18 , wherein R 18 is independently hydrogen, halogen C 1-3 alkyl, C 1-3 alkoxy, or NR 18′ R 18″ , wherein R 18′ and R 18″ are independently C 1-3 -alkyl,

R 19 is independently selected from the group consisting of

C 6-10 -aryl and 5 to 10-membered heteroaryl,

wherein each C 6-10 -aryl or 5 to 10-membered heteroaryl is optionally substituted with one or more substituent(s) independently selected from the group consisting of

C 1-6 -alkyl, C 2-6 -alkenyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, C 1-6 -alkylmercapto, halogen, cyano, nitro, hydroxy, mercapto, NR 20 R 21 , C(═O)OR 22 , SR 22 , S(O)R 22 , S(O) 2 R 22 , S(O) 2 NR 23 R 24 and C(═O)NR 23 R 24 ,

R 20 and R 21 are independently selected from the group consisting of

hydrogen, C 1-6 -alkyl, C 3-10 -cycloalkyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy-C 1-6 -alkyl, C 1 -C 6 -alkyl substituted with C 6-10 -aryl and C 1-6 -alkyl substituted with 5 to 10-membered heteroaryl, or

R 20 and R 21 together with the N atom to which they are attached form a saturated or unsaturated heterocyclic ring having 3 to 12 ring atoms, wherein 0, 1, 2 or 3 further ring atoms are selected from N, S and O,

wherein each C 1-6 -alkyl, C 2-6 -alkenyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, C 1-6 -alkylmercapto or the heterocyclic ring formed by R 20 and R 21 together with the N atom to which they are attached is optionally substituted with one or more substituents independently selected from the group consisting of

C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-10 -cycloalkyl, 4 to 10-membered heterocyclyl, C 6-10 -aryl, 5 to 10-membered heteroaryl, C 1-6 -alkoxy, carbonyl, halogen, cyano, hydroxy, mercapto, NR 20′ R 21′ , C(═O)OR 22′ , SR 22′ , S(O)R 22′ , S(O) 2 R 22′ , S(O) 2 NR 23′ R 24′ and C(═O)NR 23′ R 24′ ,

R 22 , R 23 and R 24 are independently selected from hydrogen and C 1-6 -alkyl,

R 20′ , R 21′ , R 22′ , R 23′ and R 24′ are independently selected from hydrogen and C 1-6 -alkyl,

R 25 is independently selected from hydrogen and C 1-6 -alkyl,

or a stereoisomer, physiologically acceptable salt, ester, solvate, polymorph, prodrug and mixtures thereof.

2 . The compound according to claim 1 , wherein the compound is the(S)-enantiomer.

3 . A process for preparing the compound of Formula (I) according to claim 1 comprising the step of

reacting a compound of Formula (A)

with a compound of Formula (B)

wherein L, R 1 , R 7 , R 13 , R 14 , A1, A2, A3, A4, R 19 and R 25 are defined as in claim 1 , to obtain the compound according to Formula (I).

4 . A Veterinary composition comprising

compound according to Formula (I) according to claim 1 , and

one or more physiologically acceptable excipient(s).

5 . A method of treating a disorder or disease in an animal wherein the disorder or disease is caused by helmiths comprising administering to the animal the compound according to claim 1 .

6 . A method of treating a disorder or disease in an animal wherein the disorder or disease is caused by helmiths comprising administering to the animal the composition of claim 4 .

7 . The compound according to claim 1 , wherein A1 to A4 are CH and R 1 is hydrogen and L R 7 , R 13 , R 14 , R 19 , R 25 and the chirality are defined below

No

L

R 7

R 13

R 14

R/S

R 19

R 25

1

S

isopropylamino

CH 3

H

S

H

H

2

S

morpholin-4-yl

CH 3

H

S

H

H

3

S

morpholin-4-yl

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

4

O

morpholin-4-yl

CH 3

H

S

H

H

5

O

morpholin-4-yl

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

6

O

morpholin-4-yl

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

7

O

morpholin-4-yl

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

8

O

morpholin-4-yl

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

9

S

morpholin-4-yl

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

10

S

morpholin-4-yl

═CH—CH═CH—

3,5-dichlorophenyl

H

11

S

morpholin-4-yl

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

12

O

morpholin-4-yl

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

13

S

dimethylamino

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

14

S

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

15

S

dimethylamino

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

16

S

dimethylamino

═CH—CH═CH—

3,5-dichlorophenyl

H

17

S

morpholin-4-yl

—CH 2 —CH 2 —O—

R

3,5-dichlorophenyl

H

18

S

dimethylamino

—CH 2 —CH 2 —O—

R

3,5-dichlorophenyl

H

19

S

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

20

S

dimethylamino

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

21

S

morpholin-4-yl

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

22

S

morpholin-4-yl

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

23

S

morpholin-4-yl

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

24

O

morpholin-4-yl

—CH 2 —CH 2 —O—

R

3,5-dichlorophenyl

H

25

O

morpholin-4-yl

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

26

O

morpholin-4-yl

═CH—CH═CH—

3,5-dichlorophenyl

H

27

S

morpholin-4-yl

═CH—S—

3,5-dichlorophenyl

H

28

O

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

29

O

dimethylamino

—CH 2 —CH 2 —O—

R

3,5-dichlorophenyl

H

30

O

dimethylamino

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

31

O

dimethylamino

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

32

O

dimethylamino

═CH—CH═CH—

3,5-dichlorophenyl

H

33

S

dimethylamino

═CH—S—

3,5-dichlorophenyl

H

34

O

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

35

O

dimethylamino

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

36

O

dimethylamino

═CH—CH═CH—

2,3-dichlorophenyl

H

37

O

dimethylamino

═CH—S—

2,3-dichlorophenyl

H

38

O

dimethylamino

═CH—S—

3,5-dichlorophenyl

H

39

S

dimethylamino

—CH 2 —CH 2 —O—

R

2,3-dichlorophenyl

H

40

O

dimethylamino

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

41

O

dimethylamino

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

42

S

dimethylamino

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

43

S

dimethylamino

═CH—CH═CH—

2,3-dichlorophenyl

H

44

S

dimethylamino

═CH—S—

2,3-dichlorophenyl

H

45

O

morpholin-4-yl

═CH—CH═CH—

2,3-dichlorophenyl

H

46

O

morpholin-4-yl

═CH—S—

2,3-dichlorophenyl

H

47

O

morpholin-4-yl

═CH—S—

3,5-dichlorophenyl

H

48

S

morpholin-4-yl

═CH—S—

2,3-dichlorophenyl

H

49

S

morpholin-4-yl

═CH—CH═CH—

2,3-dichlorophenyl

H

50

S

morpholin-4-yl

—CH 2 —CH 2 —O—

R

2,3-dichlorophenyl

H

51

O

morpholin-4-yl

—CH 2 —CH 2 —O—

R

2,3-dichlorophenyl

H

52

S

—SCH 3

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

53

S

—SCH 3

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

54

S

—SCH 3

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

55

S

—SCH 3

—CH 2 —CH 2 —O—

R

3,5-dichlorophenyl

H

56

O

—SCH 3

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

57

O

—SCH 3

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

58

O

—SCH 3

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

59

O

—SCH 3

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

60

O

—SCH 3

—CH 2 —CH 2 —O—

R

3,5-dichlorophenyl

H

61

O

—SCH 3

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

62

S

—SCH 2 CH 3

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

63

S

—SCH 2 CH 3

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

64

S

—SCH 2 CH 3

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

65

S

—SCH 3

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

66

S

methoxy

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

67

S

methoxy

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

68

S

methoxy

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

69

S

—SCH 3

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

70

S

ethoxy

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

71

S

ethoxy

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

72

S

ethoxy

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

73

S

—SCH 2 CH 3

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

74

S

—SCH 2 CH 3

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

75

S

—SCH 2 CH 3

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

76

O

—SCH 2 CH 3

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

77

O

—SCH 2 CH 3

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

78

O

—SCH 2 CH 3

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

79

O

—SCH 2 CH 3

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

80

O

—SCH 2 CH 3

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

81

O

—SCH 2 CH 3

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

82

S

methoxy

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

83

S

methoxy

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

84

S

methoxy

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

85

O

methoxy

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

86

O

methoxy

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

87

O

methoxy

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

88

S

ethoxy

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

89

O

ethoxy

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

90

O

ethoxy

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

91

O

ethoxy

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

92

O

ethoxy

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

93

O

ethoxy

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

94

O

methoxy

—CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

95

O

methoxy

—CH 2 —CH 2 —O—

S

2,3-dichlorophenyl

H

96

O

methoxy

—CH 2 —CH 2 —CH 2 —

S

2,3-dichlorophenyl

H

97

S

ethoxy

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

98

O

ethoxy

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

99

S

ethoxy

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

100

SO 2

dimethylamino

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

101

SO

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

102

SO 2

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

103

SO

dimethylamino

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

104

SO

dimethylamino

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

105

SO 2

dimethylamino

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

106

NH

morpholin-4-yl

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

107

NH

morpholin-4-yl

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

108

NH

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

109

NH

morpholin-4-yl

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

110

CH 2

dimethylamino

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

111

CH 2

dimethylamino

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

112

CH 2

morpholin-4-yl

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

113

CH 2

morpholin-4-yl

—CH 2 —CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

114

CH 2

morpholin-4-yl

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

115

NH

dimethylamino

—CH 2 —CH 2 —O—

S

3,5-dichlorophenyl

H

116

NH

dimethylamino

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

117

CH 2

morpholin-4-yl

—CH 2 —CH 2 —

S

3,5-dichlorophenyl

H

8 . The compound according to claim 1 , wherein A1 to A4 are each CH, R 1 is hydrogen, L is 5, R 7 is morpholin-4-yl, R 13 and R 14 is —CH 2 —CH 2 —O—, R 19 is 3,5-dichlorophenyl, R 25 is H.

9 . The compound according to claim 8 , wherein the compound is the(S)-enantiomer.